Startup Stories

AcuityMD Raises $80M to Build AI Intelligence Layer for MedTech

BOSTON: AcuityMD has raised $80 million in a Series C round at a $955 million valuation to scale its AI platform for medical technology companies. StepStone Group led the round. Benchmark, Redpoint Ventures, ICONIQ, and Atreides Management also participated. Total funding now exceeds $160 million.

The platform solves a specific commercial problem. MedTech companies operate in markets that shift fast, hospital consolidation, regulatory changes, and reimbursement updates can reshape the competitive landscape before any sales team can track it manually.

AcuityMD aggregates claims databases, FDA filings, government records, and market signals into a proprietary knowledge graph, a continuously updated map of physicians, facilities, procedures, reimbursement dynamics, and the relationships between them.

Read more: Parasail Raises $32M to Build an AI Supercloud for Agent Deployment

That data foundation is what makes the AI layer defensible. More than 400 MedTech companies use the platform today, including 16 of the top 20 globally. Customers have used it to identify over $34 billion in commercial pipeline. General AI tools cannot replicate that kind of domain-specific context, and that is precisely the argument AcuityMD makes to enterprise buyers.

Read more: nEye.ai Raises $80M to Build Optical Switches for AI Data Centres

The new funding accelerates three priorities. First, it builds out AcuityAI, an agentic AI system currently in open beta that lets sales reps and commercial leaders query the platform in natural language and receive immediate, actionable territory plans.

Second, it deepens the MedTech ontology powering the data model. Third, it expands the platform beyond commercial sales into the full product lifecycle, research, development, and launch phases for next-generation medical devices.

CEO Mike Monovoukas put the positioning simply. AI will transform MedTech, but only with the right context embedded in the workflows where decisions actually get made. AcuityMD’s claim is that it is that context layer.

Amita Parul

Amita Parul is an Independent journalist with experience in reporting and commentary on current events and sociopolitical developments. She contributes original reporting and analysis that aligns with Tea4Tech’s editorial standards for accuracy, transparency, and context, focusing on business and technology trends. || Amita covers emerging news stories and provides explanatory insights that help readers understand both the events and their implications.

Recent Posts

Amid Backlash, Meta Goes Camera-Free With New AI Glasses

California: Meta introduced its first pair of camera-free AI glasses on Wednesday at its Connect…

4 weeks ago

Anthropic Brings Claude Chat and Cowork Together Into a Single Window

Bengaluru: Anthropic has combined Claude's chat and Cowork into one interface, so users no longer…

1 month ago

OpenAI Goes All In on Hardware, Buys Glass Imaging for $300M+

California: OpenAI has reportedly acquired Glass Imaging, a startup specializing in AI-enhanced smartphone camera technology,…

1 month ago

OpenAI Launches GPT-6 Astra With Advanced Computer and AI Capabilities

New Delhi: OpenAI has launched GPT-6 Astra, its latest and most advanced AI model, with…

1 month ago

India’s Rilo Joins Adobe in AI Marketing Automation Deal

New Delhi: Adobe has acquired Rilo, an India based marketing intelligence startup, in a deal…

2 months ago

Anthropic Levels Up Claude Fable 5.1 With More Power, Less Cost

New York: Anthropic has launched Claude Fable 5.1 and Claude Mythos 5.1, its latest AI…

2 months ago